Add a minimally invasive canaloplasty step to cataract surgery
Part of Eyes & vision clinical trials.
This trial compares standard cataract surgery alone versus cataract surgery plus a procedure to improve fluid drainage in the eye. It is intended for people with mild to moderate open-angle glaucoma, to see if adding this step helps control eye pressure and preserve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate primary open-angle glaucoma in the study eye
- Your cataract is significant enough that it needs surgery
- You are using 1 to 4 glaucoma pressure-lowering eye drops (or similar medicines) and your eye pressure meets the trial target
- You have not had certain past glaucoma procedures in the study eye (like trabeculoplasty, stents, bleb surgery, or prior canaloplasty/goniotomy/trabeculotomy)
- You do not have a type of glaucoma the trial excludes (like angle-closure, traumatic, congenital, uveitic, or neovascular glaucoma)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a specific glaucoma surgery (canaloplasty) works on its own for people with mild to moderate primary open-angle glaucoma. It may help if drops (eye medicines) do not work well for you or you need fewer eye drops.
This trial tests a surgical system for people with mild to moderate open-angle glaucoma. It may be an option if you are having cataract surgery or have already had it, and your eye pressure is not well controlled with medications.
This trial looks at whether placing a small glaucoma implant at the same time as cataract surgery can better control eye pressure in people with primary open-angle glaucoma. It may help reduce the need for medicines or improve control, depending on how your eyes respond.
This study enrolls people who have cataracts and primary open-angle glaucoma that is being treated with eye drops. It will look at how well the Hydrus microstent works after approval, especially for lowering eye pressure safely.
This trial tests a surgery that combines cataract removal with a new technique to lower eye pressure in people who have both primary open-angle glaucoma and cataracts. It aims to see if this combined surgery is safe and effective.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.